Telomir Pharmaceuticals Inc Sustainability Reports

Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG01K4SG4R3

No reports are currently available in our catalogue.